About Sutro Biopharma, Inc.

Sutro Biopharma Inc. engages in the drug discovery, development and manufacturing of pharmaceutical products. Its products technologies include XpressCF, anti-body drug conjugates, bispecifics & engineered antibodies and cGMP facility. The company was founded by James R. Swartz and Sutanto Widjaja in June 2003 and is headquartered in South San Francisco, CA.

At the moment the company generates 51M USD in revenues.

On its last earning announcement, the company reported a loss of -6.44$ per share.

The book value per share is 5.18$

Sutro Biopharma, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
51M - -44M -87.00% -42M -6.44 - - 23M 5.18 -58M -2M -60M